Seeking a SHORT-TERM, HIGH RETURN PROJECT to bank on?
* This 5-year investment offers 10% annual interest and attractive convertible options upon maturity.
GREENLAND ORGANIC MEDICAL PRODUCTS INC. (www.greenlandheals.com) is a Federally Registered Organic Pharmaceutical Producer targeting what Health Canada calls a “rising medical crisis”. This project’s focus is the commercial production of clinically-established medical treatments in the form of raw and processed cannabis, concentrates, oils, CBD/THC tablets, teas and more.
GREENLAND is pursuing ISO standardization, producing all raw cannabis and medicinal organics in-house to best manage quality control. The corporation is employing a unique, industry-changing Organic Growth Patent (2016 IIP) to meet commercial demand. Agriculture and Agri-Food Canada has noted their growth model can consistently and sustainably produce 6-8 TIMES MORE CANNABIS PER SQUARE FOOT at less cost than conventional methods in use today. GREENLAND is launching this initiative with 1.3 million square feet of year-round growth-space, processing buildings, and dedicated lab facilities.
Recognized as the world’s first SUPER-PRODUCER of clean, organically grown-for-purpose cannabis crops. Whereby evaluated/acknowledged by Agriculture and Agri-Food Canada, CIBC Corporate BMO Business and EquityNet Analytics:
* First-year yields between 10.1 – 11 tonnes, with under 10% operational costs.
* Gross production doubling every 2-3 years, or exponentially as per market demand.
* Medicinal production, institutional partnerships, and expansion grows accordingly.
* EXPONENTIAL-scales of Return On (principal) Investment are available with this opportunity.
GREENLAND serves individual patients, commercial, and healthcare entities that require an uninterrupted, high turnover supply of clinically-efficative treatments while demanding unprecedented safety standards and accessibility (reliably available at fractional cost).
TYPE I MEMBERSHIP: Medical and Commercial Distribution Memberships
– Secured fractional pricing (largest stable margins, regardless of market variance)
– Supply on demand (keep shelves full & never run out of popular items)
– Unmatched quality assurance (reliable, federally trusted, and safe)
– Secure and personalized account management
TYPE II MEMBERSHIP: Production Care and Acess Program (PCAP) for individual patients.
– Secured lowest pricing below retail MSRP. May be subject to health insurance coverage.
– Always available treatment specific formulations, in client-preferred formats and options.
– Unmatched quality assurance (reliable, federally trusted, and safe)
– Secure and personalized account management
From over 18,000 acreditted clinical studies and consensus of treatment outcomes, GREENLAND has identified a scheduled range of effective treatment options under their own respective medical programs. In regions outside of Canada and where lawfully permitted, these include:
CLASS (1-4) PRESCRIPTION MEDICINES (Treatment Formulations With MSRP)
-Life-saving treatments, maintenance, and recovery.
CLASS (5) NON-PRESCRIPTION MEDICINES (Treatment Formulations With MSRP)
-Health & Wellness
-Personally Declared For Medical Use* Products.
Consumer Supply Chain Support (Commercial Only)
-PureDose THC and CBD Decarboxylated Tabs (3000mg – 05mg).
-Dedicated Production of Select Raw or Dried Heritage and Hybrid Cannabis Strains.
Diversity Of Medication Options
-Lifestyle, health and age-appropriate dosage options.
ASSOCIATE BOTANICAL OFFICER
Possessing over thirty years of applied horticultural and botanical sciences throughout various United Nations food production, organic seed-strain preservation and protection initiatives, doctor Gabremariam is an important contributor towards the corporation’s success.
Acting as Greenland’s organic engineer and overseer, he contributes a lifetime of knowledge to ensure quality, quotas and growth schedules are executed flawlessly.
HEAD OF SCIENTIFIC RESEARCH
Dr. Andrew *** contributes his 25+ years of expertise as a Senior Research Scientist for Merck Pharmaceuticals (USA), to ensure Greenland product quality and standards are met.
HEAD OF SUPPLY CHAIN AND LOGISTICS
Pedro contributes his 25 years of adept logistics management with Canadian Blood Services to ensure all of Greenland’s needs are met.
To find out if this company and others are accepting funding, Sign up as Investor.
Funding Goal$25,000,000
Funding Raised So FarSign up as Investor
Funding Commitments$15,000
Funding Remaining$24,985,000
Funding TypeConvertible Debt
Pre-Money Valuation Sign up as Investor
Investor Ownership Sign up as Investor
Interest / Dividend Sign up as Investor
Previous Funding Sign up as Investor